| Toremifene studied in …STUDIED_INderived23 of 23show fewer |
|---|
| → studied in | NCT05891093Phase 3 · recruiting Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00106691Phase 3 · completed Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) · 23 trials list this drug (1 active) | — | — | Prostatic Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05801705unknown Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study · 23 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666805unknown Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344940Phase 4 · completed Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506790Phase 2 · unknown Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03925233unknown Breast Cancer Treatment Based on Organ-like Culture · 23 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03238703Phase 4 · withdrawn Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03351062Phase 3 · unknown Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer · 23 trials list this drug (1 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003865Phase 2 · withdrawn Toremifene in Treating Patients With Ovarian Cancer · 23 trials list this drug (1 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02097459Phase 3 · unknown Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020735Phase 2 · completed Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer · 23 trials list this drug (1 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00044291Phase 3 · completed Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer · 23 trials list this drug (1 active) | — | — | Neoplasm,Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02353429Phase 2 · unknown Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets · 23 trials list this drug (1 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02132390Phase 3 · unknown Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00010322Phase 3 · terminated Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00129142Phase 3 · completed Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy · 23 trials list this drug (1 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01214291Phase 3 · withdrawn Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer · 23 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002595Phase 2 · completed Toremifene in Treating Patients With Desmoid Tumors · 23 trials list this drug (1 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002529Phase 3 · completed Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer · 23 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00437359Phase 2 · terminated Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer · 23 trials list this drug (1 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00267553Phase 3 · terminated Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer · 23 trials list this drug (1 active) | — | — | Neoplasm,Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00097344Phase 3 · terminated The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer · 23 trials list this drug (1 active) | — | — | Neoplasm,Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |